198 related articles for article (PubMed ID: 35301431)
1. Hypoxia-induced GLT8D1 promotes glioma stem cell maintenance by inhibiting CD133 degradation through N-linked glycosylation.
Liu K; Jiang L; Shi Y; Liu B; He Y; Shen Q; Jiang X; Nie Z; Pu J; Yang C; Chen Y
Cell Death Differ; 2022 Sep; 29(9):1834-1849. PubMed ID: 35301431
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
Soeda A; Park M; Lee D; Mintz A; Androutsellis-Theotokis A; McKay RD; Engh J; Iwama T; Kunisada T; Kassam AB; Pollack IF; Park DM
Oncogene; 2009 Nov; 28(45):3949-59. PubMed ID: 19718046
[TBL] [Abstract][Full Text] [Related]
3. Matrix stiffness promotes glioma cell stemness by activating BCL9L/Wnt/β-catenin signaling.
Tao B; Song Y; Wu Y; Yang X; Peng T; Peng L; Xia K; Xia X; Chen L; Zhong C
Aging (Albany NY); 2021 Feb; 13(4):5284-5296. PubMed ID: 33535177
[TBL] [Abstract][Full Text] [Related]
4. CD133 glycosylation is enhanced by hypoxia in cultured glioma stem cells.
Lehnus KS; Donovan LK; Huang X; Zhao N; Warr TJ; Pilkington GJ; An Q
Int J Oncol; 2013 Mar; 42(3):1011-7. PubMed ID: 23340741
[TBL] [Abstract][Full Text] [Related]
5. Mannose inhibits proliferation and promotes apoptosis to enhance sensitivity of glioma cells to temozolomide through Wnt/β-catenin signaling pathway.
Fei YQ; Shi RT; Zhou YF; Wu JZ; Song Z
Neurochem Int; 2022 Jul; 157():105348. PubMed ID: 35490896
[TBL] [Abstract][Full Text] [Related]
6. Cardiac glycosides suppress the maintenance of stemness and malignancy via inhibiting HIF-1α in human glioma stem cells.
Lee DH; Cheul Oh S; Giles AJ; Jung J; Gilbert MR; Park DM
Oncotarget; 2017 Jun; 8(25):40233-40245. PubMed ID: 28410215
[TBL] [Abstract][Full Text] [Related]
7. miR-150-5p suppresses the stem cell-like characteristics of glioma cells by targeting the Wnt/β-catenin signaling pathway.
Tian W; Zhu W; Jiang J
Cell Biol Int; 2020 May; 44(5):1156-1167. PubMed ID: 32009256
[TBL] [Abstract][Full Text] [Related]
8. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth.
Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
Tang Y; Berlind J; Mavila N
Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
[TBL] [Abstract][Full Text] [Related]
10. Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy.
Tomar VS; Patil V; Somasundaram K
Cell Biol Toxicol; 2020 Jun; 36(3):273-278. PubMed ID: 31758290
[TBL] [Abstract][Full Text] [Related]
11. The Development and Applications of a Dual Optical Imaging System for Studying Glioma Stem Cells.
Tai PA; Liu YL; Wen YT; Lin CM; Huynh TT; Hsiao M; Wu ATH; Wei L
Mol Imaging; 2019; 18():1536012119870899. PubMed ID: 31478435
[TBL] [Abstract][Full Text] [Related]
12. Phosphoribosylpyrophosphate Synthetase 1 Knockdown Suppresses Tumor Formation of Glioma CD133+ Cells Through Upregulating Cell Apoptosis.
Li C; Yan Z; Cao X; Zhang X; Yang L
J Mol Neurosci; 2016 Oct; 60(2):145-56. PubMed ID: 27343059
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of Wnt signaling pathway.
Yang HC; Wang JY; Bu XY; Yang B; Wang BQ; Hu S; Yan ZY; Gao YS; Han SY; Qu MQ
J Cell Physiol; 2019 May; 234(5):6783-6800. PubMed ID: 30317578
[TBL] [Abstract][Full Text] [Related]
14. BET degrader inhibits tumor progression and stem-like cell growth via Wnt/β-catenin signaling repression in glioma cells.
Tian T; Guo T; Zhen W; Zou J; Li F
Cell Death Dis; 2020 Oct; 11(10):900. PubMed ID: 33093476
[TBL] [Abstract][Full Text] [Related]
15. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
[TBL] [Abstract][Full Text] [Related]
16. Vasculogenesis and angiogenesis initiation under normoxic conditions through Wnt/β-catenin pathway in gliomas.
Vallée A; Guillevin R; Vallée JN
Rev Neurosci; 2018 Jan; 29(1):71-91. PubMed ID: 28822229
[TBL] [Abstract][Full Text] [Related]
17. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
[TBL] [Abstract][Full Text] [Related]
18. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
[TBL] [Abstract][Full Text] [Related]
19. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
20. A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells.
Ahmed EM; Bandopadhyay G; Coyle B; Grabowska A
Cell Oncol (Dordr); 2018 Jun; 41(3):319-328. PubMed ID: 29492900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
